Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Clinical Efficacy of Early Left Bundle Branch Pacing for Cardiac Resynchronization Therapy

NCT: NCT06126081 · ACTIVE_NOT_RECRUITING

NCT IDNCT06126081
StatusACTIVE_NOT_RECRUITING
Start Date2023-06-26
Completion2026-06

Brief Summary

This is a two-center, prospective randomized controlled trial. The aim of this study is to compare the clinical efficacy of early left bundle branch pacing for cardiac resynchronization therapy and guideline-directed medical therapy in heart failure with mild-reduced ejection fraction.

Frequently Asked Questions

What is Clinical Efficacy of Early Left Bundle Branch Pacing for Cardiac Resynchronization Therapy?

Clinical Efficacy of Early Left Bundle Branch Pacing for Cardiac Resynchronization Therapy is a clinical trial registered under NCT06126081. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT06126081?

The current status of NCT06126081 (Clinical Efficacy of Early Left Bundle Branch Pacing for Cardiac Resynchronization Therapy) is: ACTIVE_NOT_RECRUITING.

When did Clinical Efficacy of Early Left Bundle Branch Pacing for Cardiac Resynchronization Therapy start?

Clinical Efficacy of Early Left Bundle Branch Pacing for Cardiac Resynchronization Therapy started on 2023-06-26.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑